RNS Number : 7243V
Webis Holdings PLC
10 July 2024
 

For immediate release

10 July 2024

Webis Holdings plc

("Webis" or the "Group")

Jim Mellon joins the Webis board

Following regulatory approval, the Board of Webis, the global gaming group, is pleased to announce the appointment of Mr James ("Jim") Mellon as a Non-Executive Director of the Group. Jim is a well-known entrepreneur, investor, and author. His interests include biopharma, life sciences, property, mining, and financial services amongst others. Jim is an honorary Fellow of Oriel College, Oxford and holds a master's degree in Politics, Philosophy and Economics from Oxford University. Jim is the beneficial owner of and Chairman of Burnbrae Group Limited.

Ed Comins, Webis' Managing Director, commented:

"I am delighted to welcome Jim to the Board of Webis. His exceptional commercial experience will prove invaluable as we continue to implement our strategy, and we are sure he will make a very positive contribution to the Board."

James ("Jim") Mellon (age 67)

He has held the following directorships and/or partnerships in the past five years:

Current

Past

Acruity Limited

Binary Group Ltd

Agronomics Investment Holdings Limited

Binary Investments (Europe) Limited

Agronomics Limited

Binary Limited

Albany Management Limited

Biogerontology Research Foundation

American Federation of Aging Research

Calabrese Holdings Limited

Big Group Limited

Extreme Opportunities Limited

Bradda Head International Limited

Fast Forward Innovations Limited

Bradda Head Limited

Ferrum Limited

Bradda Head Lithium Limited

Fixed-Odds Capital (Cook Islands) Ltd

Buck Institute for Research on Aging

Global Glory Investment Limited

Burnbrae Germany East GmbH

Insilico Medicine Cayman Subco

Burnbrae Germany Limited

Insilico Medicine Cayman Topco

Burnbrae Germany Operations GmbH

Insilico Medicine Hong Kong Limited

Burnbrae Germany West GmbH

Insilico Medicine, Inc.

Burnbrae Group Limited

Interman (Hong Kong) Limited

Burnbrae Limited

Plethora Solutions Holdings plc

Burnbrae Mitte GmbH

Regent Corporate Finance Limited

Burnbrae Sachsen GmbH

Regent Fund Management (Asia) Limited

Calabrese Holdings Limited

Regent Fund Management Limited

Clean Air Capital Limited

Regent Metals Holdings Limited

Clean Food Group Limited

Shaanxi Red Dragon Resources Ltd

Compedica Holdings Limited

Speymill Deutsche Immobilien plc

Condor Gold Plc

Speymill Property Group (UK) Limited

Good Dog Food Limited

Wielandstrasse 5 Objekt GmbH

IC Technology (UK) Limited


J2 Music Limited


Juvenescence Limited


LyGenesis, Inc.


Mann Bio Pathfinder Limited


Mann Bioinvest (BVI) Limited


Mann Bioinvest Limited


Manx Financial Group plc


MediqVentures Limited


New Agrarian Company Advisors Limited


New Agrarian Company Limited


Podenco Global Limited


Portage Biotech, Inc


Powered Future Limited


Regent Pacific Group Limited


SABR Holdings Litd


SalvaRx Group Limited


SalvaRx Group PLC


SalvaRx Limited


Shellbay Investments Limited


Sleepwell Hotels (UK) Limited


Sleepwell Hotels Limited


The Longevity Forum Limited


Titec (BVI) Limited


Winter Limited


Wolseley Managers Limited


 

Jim Mellon holds 248,204,442 shares in the Group in the name of Burnbrae Limited, representing 63.1% of the issued capital.

Further information on Mr Mellon which required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies is set out in the Appendix.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

For further information:

Webis Holdings plc Tel: 01624 639396

Denham Eke

Beaumont Cornish Limited Tel: 020 7628 3396

Roland Cornish/James Biddle

Appendix: Further disclosure under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies

Jim Mellon was a director of Regent Global Fund and Undervalued Assets Greater China Fund Series III, both of which went into voluntary liquidation. These two funds were liquidated with the consent of shareholders as the directors recommended that, due to a decline in the size of the funds, they were uneconomic. There were no unsatisfied creditors.

Bigsave Holdings plc, a company of which Jim Mellon was a director, entered into a voluntary liquidation. There were no unsatisfied creditors.

On 8 April 2003, Regent Pacific Fund, a company of which Jim Mellon was a director, entered into a voluntary liquidation. There were no unsatisfied creditors.

On 9 December 2005, Undervalued Assets Fund - Series One, a company of which Jim Mellon was a director, entered into a voluntary liquidation. There were no unsatisfied creditors.

On 5 February 2008, Asian Opportunity Fund 1998 - Series I, commenced voluntary liquidation pursuant to its Articles and Association. Jim Mellon was a director within the 12 month periods preceding such date. There were no unsatisfied creditors.

On 29 January 2014, Rivington Street Holdings plc, a company of which Jim Mellon was a director, entered into a voluntary liquidation. The creditors were owed approximately £4 million, of which Jim Mellon and his interests were owed £3.8 million.

On 3 September 2015, Speymill plc, a company of which Jim Mellon was a director, entered into a voluntary liquidation and was subsequently dissolved on 6 July 2017. The combined creditors of the Speymill Group were approximately £4.3 million, of which Jim Mellon and his interests were owed £3.9 million.

There was an historic arrest warrant for Jim Mellon, issued by the Seoul South Korea prosecutor's office on 19 December 2000 and subsequently reissued on 14 January 2004. The warrant was due to remain valid and effective until 12 March 2010. The arrest warrant pertains to an alleged involvement in a conspiracy to manipulate the share price of Regent Securities Co., Ltd. Mr Mellon has informed the Company that he absolutely and categorically denies that this allegation has any substance. No evidence was produced against him and no further proceedings have taken place with no further developments in this matter since 2010.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUKUURSVUBRAR